DSGN

DESIGN THERAPEUTICS INC

DSGN·25056L103·US·Common Stock·Healthcare - Biotechnology-Activist

DSGN (DESIGN THERAPEUTICS INC) is held by 82 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($31.6M), Point72 Asset Management, L.P. ($29M), BAKER BROS. ADVISORS LP ($27.5M). Net institutional sentiment: Bullish.

82
Holders
Avg rating(17 Elite)
$241.8M
Total Value
72% (84)
Fund Consensus
56 buying - 22 selling
DSGNSmart Money Verdict
View all
Held by 82 funds
17 elite
Who's Trading
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.5.1%Jun 9, 2026
ActivistSOSR One Capital Fund I Aggregator, LP10.6%Mar 11, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.9.4%Feb 17, 2026
ActivistLGLogos Global Management LP4.4%Nov 18, 2025
InsiderWAWilliam ArsaniSell $1.8MAug 13, 2025
InsiderWAWilliam ArsaniSell $1.1MAug 13, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3M(+103.4%)$31.6M0.3%+61.14%
56
Decreased
2.7M(-49.3%)$29M0.0%+110.76%
0
Increased
2.6M(+15.8%)$27.5M0.2%+48.55%
40
Increased
2.1M(+0.8%)$22.7M0.0%+140.22%
29
Increased
1.7M(+47.9%)$18.6M0.1%+110.14%
46
New
1.3M$14.4M0.0%+51.90%
39
Increased
961,501(+1.9%)$10.2M0.0%+146.24%
28
Increased
798,411(+3.5%)$8.5M0.0%+136.23%
28
Increased
692,518(+1.9%)$7.4M0.0%-2.87%
28
Increased
659,575(+1.8%)$7M0.0%+391.51%
28
Decreased
656,565(-6.5%)$7M0.0%+84.75%
0
Increased
504,718(+86.5%)$5.4M0.0%+88.89%
42
Increased
470,270(+7.2%)$5M0.0%+220.78%
29
Increased
431,840(+45.0%)$4.6M0.0%+126.94%
36
Increased
408,200(+42.2%)$4.3M0.0%+179.74%
36
Increased
300,279(+4.8%)$3.2M0.0%+6.50%
28
Increased
289,385(+48.7%)$3.1M0.0%+54.08%
36
Increased
241,485(+1.9%)$2.6M0.0%+7.87%
27
Decreased
231,513(-49.7%)$2.5M0.0%+25.24%
0
New
195,658$2.1M0.0%+51.90%
36

Showing 1-20 of 84

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used